SCYNEXIS
SCYNEXIS, Inc. is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant.
Last updated on
About SCYNEXIS
Founded
2000Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$252MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
Jersey CityState
New JerseyCountry
United StatesTech Stack (52)
